Cell Isolation Market

The cell isolation market is expected to grow from USD 4.6 billion in 2024 to USD 8.4 billion by 2029, at a CAGR of 12.9%. Growing focus on personalized treatment and increased government financing for cell-based research are some of the factors propelling this market's expansion.

Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), BD (US), and Merck KGaA (Germany) are among the top companies in the global cell isolation industry. In order to hold onto their positions in the global cell isolation market, players have employed a range of strategies, such as collaborations, agreements, product launches, and geographic expansions.

To know about the assumptions considered for the study download the pdf brochure

Danaher Corporation (US)

Danaher Corporation offers a range of technology that enables it to be a leader in cell separation and analysis. Its advantages include greater automation, precise instrumentation, and extensive operations that improve cell separation reliability and efficiency. Using cutting-edge technology, the company allows researchers to achieve accurate results and accelerate breakthroughs in the field of cellular biology. Danaher has a strong presence in the market owing to its robust sales and distribution network. Through its Life Sciences and Biotechnology divisions, Beckman Coulter and Cytiva, provide a wide variety of cell isolation products. To further establish itself in the market, Danaher prioritizes inorganic growth techniques like partnerships, acquisitions, and expansions. For example, in March 2023, Danaher Corporation collaborated with the University of Pennsylvania to develop new technologies to improve the consistency of clinical outcomes for patients while also overcoming production constraints in the delivery of next-generation tailored cells.

Merck KGaA (Germany)

Merck KGaA offers a large selection of kits and reagents for cell separation from complex sources, demonstrating their commitment to both quality and innovation. Their state-of-the-art tools and technical support benefit researchers by ensuring precise and efficient cell separation. Merck KGaA provides specific products and expertise to meet various research requirements. In addition, by adapting strategic partnerships and investments in state-of-the-art research centers, the company is strengthening its potential for cell expansion. These investments support international progress in cell therapy and bioprocessing applications while strengthening their ability to scale up cell-based technologies. For instance, in April 2024, Merck invested more than USD 300 million (300 million euros) in a new research center at Darmstadt. The goal of this Advanced Research Center is to develop solutions for mRNA applications, antibody synthesis, and other biotechnological production requirements.

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific Inc. leads the cell isolation industry with a diverse product portfolio and a strong global presence, ensuring accessibility and support worldwide. Their drive to innovation ensures cutting-edge solutions, as demonstrated by items such as Gibco CTS Detachable Dynabeads. To fulfill the research and clinical needs, the company offers technical support for customers, scalable solutions, and adaptable platforms. The company is focused on partnerships and collaborations.  In February 2024, Thermo Fisher Scientific Inc. signed an agreement with Multiply Labs (US) to automate the cell therapy manufacturing process. By combining Multiply Labs' robotic technology with Thermo Fisher instruments, the companies aim to lower costs, shorten manufacturing time, and improve scalability.

Related Reports:

Cell Isolation/Separation Market by Product (Consumables [Media, Kits] Instruments), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose Tissue), Technique (Centrifugation, Filtration), Application (Biomolecule, Cancer) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]